ÌÇÐÄÊÓÆµ

Olaoluwa Okusaga

Okusaga

Olaoluwa Okusaga, M.D.

Associate Professor

Positions

Associate Professor
Psychiatry & Behavioral Sciences
ÌÇÐÄÊÓÆµ of Medicine
Houston, TX, United States
Staff Psychiatrist
Michael E DeBakey VA Medical Center
Houston, Texas, United States

Education

MBChB from Ogun State University
10/1999 - Ago-Iwoye, Ogun State, Nigeria
MPH from University of Edinburgh
12/2008 - Edinburgh, United Kingdom
Residency at Saint Elizabeths Hospital
06/2012 - Washington, District of Columbia, United States

Certifications

Board Certified
#65408
American Board of Psychiatry and Neurology

Professional Interests

  • Schizophrenia Research
  • Psychoneuroimmunology
  • Psychopharmacology

Professional Statement

My clinical expertise is in the psychopharmacological management of adult patients with difficult-to-treat schizophrenia spectrum and other psychotic disorders.

Selected Publications

  • Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, Scrandis DA, Severance E, Cabassa JA, Balis T, Postolache TT. " " J Affect Disord. 2011 Apr ; 130 (1-2) : 220-5.
    Pubmed PMID: .
  • Boozalis T, Teixeira AL, Cho RY, Okusaga O.. " " Front Public Health. 2018 Jan ; 22 (5)
    Pubmed PMID: .
  • Okusaga O, Duncan E, Langenberg P, Brundin L, Fuchs D, Groer MW, Giegling I, Stearns-Yoder KA, Hartmann AM, Konte B, Friedl M, Brenner LA, Lowry CA, Rujescu D, Postolache TT.. " " J Psychiatr Res. 2016 Jan ; 72 : 74-81.
    Pubmed PMID: .
  • Boozalis T, Devaraj S, Okusaga OO. " " Psychiatr Q. 2019 Mar ; 90 (1) : 101-110.
    Pubmed PMID: .

Memberships

American Psychiatric Association
Society of Biological Psychiatry
American Society of Clinical Psychopharmacology
Member (07/2010)

Funding

MEDVAMC Seed Award
$50,000.00   (10/01/2020 - 09/30/2021)
Grant funding from Michael E. DeBakey VA Medical Center
Antipsychotic-Induced Metabolic Syndrome (AIMS) in Schizophrenia: A Preliminary In Vitro Study of Alpha Lipoic Acid/Acetyl-L-Carnitine

to edit your profile